Nausheen Ahmed, Medical Director of BMT Survivorship Program at The University of Kansas, shared a post on LinkedIn:
“New Publication Alert!
I’m thrilled to share that our latest article, ‘From Vision to Viability: Developing Infrastructure for Cell and Gene Therapy Programs’, is now published online in Transplantation and Cellular Therapy! Special thanks to Zahra Mahmoudjafari, for driving this effort forward.
In this work, we outline a practical, comprehensive framework for building institutional infrastructure that enables safe, efficient, and sustainable delivery of cutting-edge cell and gene therapies (CGTs). These transformative therapies — including CAR-T cells, tumor-infiltrating lymphocytes, and emerging gene-based approaches — offer unprecedented potential for patients but require robust strategic, operational, financial, and quality systems to translate that promise into real-world care.
We give broad overview on aspects to consider:
- Strategic planning and governance for CGT program development
- Operational readiness and multidisciplinary coordination
- Pharmacy integration and technology/data infrastructure
- Financial modeling, payer strategy, and sustainability
- Quality management, accreditation, and outreach
- Practical pathways to improve access and patient care continuity
This article reflects collaborative expertise and aims to serve as a blueprint for institutions — from emerging centers to established academic programs — ready to navigate the complexities of CGT implementation in today’s rapidly evolving therapeutic landscape.”
Title: From Vision to Viability: Developing Infrastructure for Cell and Gene Therapy Programs
Authors: Zahra Mahmoudjafari, Joseph McGuirk, Nausheen Ahmed
Read the Full Article in Transplantation and Cellular Therapy.
More posts featuring Nausheen Ahmed.